202 related articles for article (PubMed ID: 25577957)
41. Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene.
Chaki M; Mukhopadhyay A; Chatterjee S; Das M; Samanta S; Ray K
Mol Vis; 2005 Jul; 11():531-4. PubMed ID: 16056219
[TBL] [Abstract][Full Text] [Related]
42. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
Ko JM; Yang JA; Jeong SY; Kim HJ
Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
[TBL] [Abstract][Full Text] [Related]
43. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
[TBL] [Abstract][Full Text] [Related]
44. Mutation analysis of the tyrosinase gene in oculocutaneous albinism.
Camand O; Marchant D; Boutboul S; Péquignot M; Odent S; Dollfus H; Sutherland J; Levin A; Menasche M; Marsac C; Dufier JL; Heon E; Abitbol M
Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837
[TBL] [Abstract][Full Text] [Related]
45. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism.
Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C
Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472
[TBL] [Abstract][Full Text] [Related]
46. SLC45A2 variations in Indian oculocutaneous albinism patients.
Sengupta M; Chaki M; Arti N; Ray K
Mol Vis; 2007 Aug; 13():1406-11. PubMed ID: 17768386
[TBL] [Abstract][Full Text] [Related]
47. [Prenatal genetic diagnosis for two Chinese families affected with oculocutaneous albinism type Ⅱ].
Hu H; Wang H; Jia Z; Xie Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Aug; 31(4):424-7. PubMed ID: 25119903
[TBL] [Abstract][Full Text] [Related]
48. Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.
Li C; Chen Q; Wu J; Ren J; Zhang M; Wang H; Li J; Tang Y
J Biol Chem; 2022 May; 298(5):101922. PubMed ID: 35413289
[TBL] [Abstract][Full Text] [Related]
49. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
[TBL] [Abstract][Full Text] [Related]
50. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
[No Abstract] [Full Text] [Related]
51. Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.
Tanita M; Matsunaga J; Miyamura Y; Dakeishi M; Nakamura E; Kono M; Shimizu H; Tagami H; Tomita Y
J Hum Genet; 2002; 47(1):1-6. PubMed ID: 11829136
[TBL] [Abstract][Full Text] [Related]
52. African origin of an intragenic deletion of the human P gene in tyrosinase positive oculocutaneous albinism.
Durham-Pierre D; Gardner JM; Nakatsu Y; King RA; Francke U; Ching A; Aquaron R; del Marmol V; Brilliant MH
Nat Genet; 1994 Jun; 7(2):176-9. PubMed ID: 7920637
[TBL] [Abstract][Full Text] [Related]
53. [Genetics of oculocutaneous albinism].
Zühlke C; Stell A; Käsmann-Kellner B
Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
[TBL] [Abstract][Full Text] [Related]
54. Comprehensive analysis of spectral distribution of a large cohort of Chinese patients with non-syndromic oculocutaneous albinism facilitates genetic diagnosis.
Zhong Z; Gu L; Zheng X; Ma N; Wu Z; Duan J; Zhang J; Chen J
Pigment Cell Melanoma Res; 2019 Sep; 32(5):672-686. PubMed ID: 31077556
[TBL] [Abstract][Full Text] [Related]
55. Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.
Park KC; Park SK; Lee YS; Youn SW; Park BS; Kim KH; Lee ST
Jpn J Hum Genet; 1996 Sep; 41(3):299-305. PubMed ID: 8996965
[TBL] [Abstract][Full Text] [Related]
56. [Mutation screening of the TYR and P gene in three patients with oculocutaneous albinism].
Dai C; Li W; Gao B; Li LY; Lu GX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):373-7. PubMed ID: 18683130
[TBL] [Abstract][Full Text] [Related]
57. Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families.
Wei AH; Zang DJ; Zhang Z; Yang XM; Li W
J Genet Genomics; 2015 Jun; 42(6):279-86. PubMed ID: 26165494
[TBL] [Abstract][Full Text] [Related]
58. Mutation Analysis of 63 Northwest Chinese Probands with Oculocutaneous Albinism.
Chuan Z; Yan Y; Hao S; Zhang Q; Zhou B; Feng X; Wang X; Liu F; Zheng L; Cao Z; Ma X
Curr Eye Res; 2021 Jan; 46(1):140-143. PubMed ID: 32552135
[TBL] [Abstract][Full Text] [Related]
59. Mutation in and lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3".
Boissy RE; Zhao H; Oetting WS; Austin LM; Wildenberg SC; Boissy YL; Zhao Y; Sturm RA; Hearing VJ; King RA; Nordlund JJ
Am J Hum Genet; 1996 Jun; 58(6):1145-56. PubMed ID: 8651291
[TBL] [Abstract][Full Text] [Related]
60. Molecular basis of oculocutaneous albinism.
Oetting WS; King RA
J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]